Yayın: Mast cells, vasoactive intestinal peptide (VIP), and the hemorrhagic shock: a possible relationship?
| dc.contributor.author | Tunçel, Neşe | |
| dc.contributor.orcid | 0000-0003-2700-5840 | |
| dc.date.accessioned | 2025-11-13T12:16:17Z | |
| dc.date.issued | 1993-12-31 | |
| dc.identifier.doi | https://doi.org/10.14748/bmr.v2.210 | |
| dc.identifier.endpage | 37 | |
| dc.identifier.issn | 1310-392X | |
| dc.identifier.issue | 0 | |
| dc.identifier.openalex | W2044069699 | |
| dc.identifier.startpage | 37 | |
| dc.identifier.uri | https://hdl.handle.net/11421/9505 | |
| dc.identifier.uri | https://doi.org/10.14748/bmr.v2.210 | |
| dc.identifier.volume | 2 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Biomedical Reviews | |
| dc.rights | openAccess | |
| dc.subject | Degranulation | |
| dc.subject | Vasoactive intestinal peptide | |
| dc.subject | Histamine | |
| dc.subject | Endogeny | |
| dc.subject | Medicine | |
| dc.subject | Compound 48/80 | |
| dc.subject | Shock (circulatory) | |
| dc.subject | Mast cell | |
| dc.subject | (+)-Naloxone | |
| dc.subject | Immunology | |
| dc.subject | Pharmacology | |
| dc.subject | Internal medicine | |
| dc.subject | Neuropeptide | |
| dc.subject | Receptor | |
| dc.subject | Opioid | |
| dc.subject.sdg | 3 | |
| dc.title | Mast cells, vasoactive intestinal peptide (VIP), and the hemorrhagic shock: a possible relationship? | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5036918993 |
